Extensive-stage small cell lung cancer (SCLC) is a challenging diagnosis, as it indicates the cancer has spread beyond the chest to other parts of the body. Treatment for this stage typically involves a combination of chemotherapy and immunotherapy, aiming to control the disease and improve survival. Recent data showed that the addition of immunotherapy (atezolizumab…
Small Cell Lung Cancer
The treatment of early-stage small cell lung cancer (SCLC) has traditionally involved a combination of chemotherapy and radiation therapy. For patients with localized disease, the standard approach includes drugs such as cisplatin or carboplatin paired with etoposide, followed by radiation to the chest to target residual cancer cells. Prophylactic cranial irradiation (PCI) can also be…